32 results on '"Fasolini, Marina"'
Search Results
2. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors
3. Identification of unprecedented ATP-competitive choline kinase inhibitors
4. Epitope-tagged P0 Glycoprotein Causes Charcot-Marie-Tooth-like Neuropathy in Transgenic Mice
5. Peripheral Nerve Dysmyelination Due to P0 Glycoprotein Overexpression Is Dose-Dependent
6. P0-Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells
7. Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor
8. Abstract 5163: Characterization of NMS-E194, a selective and potent PERK inhibitor with efficacy in the KMS-11 multiple myeloma
9. Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor
10. Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor
11. Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy
12. Optimization of Diarylthiazole B-Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical Effect
13. NMS-P937, a 4,5-dihydro-1 H-pyrazolo[4,3- h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor
14. Tetramerization Dynamics of C-terminal Domain Underlies Isoform-specific cAMP Gating in Hyperpolarization-activated Cyclic Nucleotide-gated Channels
15. Structural basis for CARM1 inhibition by indole and pyrazole inhibitors
16. NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor
17. First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery
18. First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery
19. Optimization of Diarylthiazole B-Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical Effect.
20. Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening
21. Hot Spots in Tcf4 for the Interaction with β-Catenin
22. NMR-Based Screening with Competition Water−Ligand Observed via Gradient Spectroscopy Experiments: Detection of High-Affinity Ligands
23. Epitope-Tagged P0Glycoprotein Causes Charcot-Marie-Tooth–Like Neuropathy in Transgenic Mice
24. Peripheral Nerve Dysmyelination Due to P0Glycoprotein Overexpression Is Dose-Dependent
25. P0- Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells.
26. Peripheral Nerve Dysmyelination Due to P0 Glycoprotein Overexpression Is Dose-Dependent.
27. P0‐CreTransgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells
28. Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening.
29. Hot spots in Tcf4 for the interaction with beta-catenin.
30. NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands.
31. P 0 -Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells.
32. Peripheral Nerve Dysmyelination Due to P 0 Glycoprotein Overexpression Is Dose-Dependent.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.